SCHEMBL2544384

SCHEMBL2544384

CC(N)C(=O)NC(CS)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.69
KDM4E B2RXH2 1/20 0.59
MAPT P10636 1/20 0.59
THRB P10828 1/20 0.59
ALOX15 P16050 1/20 0.59
NFKB1 P19838 1/20 0.59
PTGS2 P35354 1/20 0.59
THPO P40225 1/20 0.59
RECQL P46063 1/20 0.59
BLM P54132 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
FOLH1 Q04609 1/20 0.46
NOD1 Q9Y239 1/20 0.46
DPP4 P27487 1/20 0.44
ENPEP Q07075 3/20 0.42
MME P08473 3/20 0.42
PTGS1 P23219 1/20 0.41
SLC7A11 Q9UPY5 1/20 0.41
PAX8 Q06710 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29516656 1.00 ACE (0.69) ACEKDM4EMAPTTHRBALOX15
SCHEMBL2544386 1.00 ACE (0.69) ACEKDM4EMAPTTHRBALOX15
SCHEMBL29511093 1.00 ACE (0.69) ACEKDM4EMAPTTHRBALOX15
SCHEMBL28303549 1.00 ACE (0.69) ACEKDM4EMAPTTHRBALOX15
SCHEMBL29476622 1.00 ACE (0.69) ACEKDM4EMAPTTHRBALOX15
Water SCHEMBL2599749 0.98 ACE (0.67) ACEKDM4EMAPTTHRBALOX15
SCHEMBL31599213 0.98 ACE (0.67) ACEKDM4EMAPTTHRBALOX15
Water SCHEMBL2599751 0.98 ACE (0.67) ACEKDM4EMAPTTHRBALOX15
SCHEMBL31696942 0.96 ACE (0.65) ACEKDM4EMAPTTHRBALOX15
SCHEMBL29850413 0.93 ACE (0.61) ACEKDM4EMAPTTHRBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118460849-A Method for recycling valuable metals of waste lithium batteries by using modified polypeptide green solution 中南大学 2024-08-09 CN claimed
CN-110205282-B Cell culture medium comprising small peptides 生命技术公司 2024-07-05 CN claimed
EP-4170016-A1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation (US) 2023-04-26 EP claimed
US-20220263033-A1 ETCHING PROCESS OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2022-08-18 US claimed
US-11365389-B2 Cell culture medium comprising small peptides Life Technologies Corporation (US) 2022-06-21 US claimed
US-12529029-B2 Cell culture medium comprising small peptides Life Technologies Corporation (US) 2026-01-20 US disclosed
CN-106520658-B Cell culture medium comprising small peptides 生命技术公司 2024-09-24 CN disclosed
CN-110205282-B Cell culture medium comprising small peptides 生命技术公司 2024-07-05 CN disclosed
US-20230365919-A1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation 2023-11-16 US disclosed
EP-4170016-A1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation (US) 2023-04-26 EP disclosed
EP-3168295-B1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES LIFE TECHNOLOGIES CORP (US) 2022-11-02 EP disclosed
EP-3165600-B1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES LIFE TECHNOLOGIES CORP (US) 2022-11-02 EP disclosed
EP-3165600-A1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation (US) 2017-05-10 EP disclosed
US-20170058256-A1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation 2017-03-02 US disclosed
EP-2561065-B1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES LIFE TECHNOLOGIES CORP (US) 2016-11-09 EP disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 US disclosed
EP-2561065-A2 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation (US) 2013-02-27 EP disclosed
WO-2011145639-A1 CRYSTAL OF OXIDIZED ALANYLCYSTEINE AND METHOD FOR PRODUCING SAME 協和発酵バイオ株式会社 (JP) 2011-11-24 WO disclosed
US-20110262965-A1 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation (US) 2011-10-27 US disclosed
WO-2011133902-A2 CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES Life Technologies Corporation (US) 2011-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529029-B2 Cell culture medium comprising small peptides SLC7A11, SLC7A5, SLC6A15 ACE 2179/4885KDM4E 4043/4885MAPT 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.